{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Houston",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81002",
      "recalling_firm": "Pharm D Solutions, LLC",
      "address_1": "1304 S Loop W",
      "address_2": "N/A",
      "postal_code": "77054-4010",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0185-2019",
      "product_description": "Sermorelin/GHRP-2/Theanine/Mannitol 15 mg/6 mg/75 mg/300 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1731-10",
      "product_quantity": "108 vials",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20180910",
      "center_classification_date": "20181101",
      "termination_date": "20210205",
      "report_date": "20181107",
      "code_info": "Lot: 07062018:05 Discard by: 1/2/2019"
    }
  ]
}